• Login
Saturday, April 4, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

Apollo Hospitals promoters to sell stake worth Rs 1,395 crore in block deal: Report

GenevaTimes by GenevaTimes
August 21, 2025
in Business
Reading Time: 2 mins read
0
Apollo Hospitals promoters to sell stake worth Rs 1,395 crore in block deal: Report
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


Promoters of Apollo Hospitals Enterprise are likely to sell shares worth Rs 1,395 crore in the company via block deal on Friday. The floor price is likely set at Rs 7,747 per share, ET Now reported.

This is a 2% discount over Thursday’s closing price of Rs 7,920. Apollo Hospitals shares closed with gains of Rs 37 or 0.47%.

While details of the deal are awaited, CNBC-TV18 reported that Suneetha Reddy will sell equity up to 1.25% stake. She currently holds 3.36% stake accounting over 48.34 lakh shares.

Apollo Hospitals Enterprise reported a consolidated net profit of Rs 433 crore in Q1, up 42% compared to Rs 305 crore reported in the year ago period. The profit after tax (PAT) was attributable to the owners of the company. Company’s revenue from operations in the quarter grew 15% to Rs 5,842 crore versus Rs 5,086 crore in Q1FY25.

The PAT was 11% higher on a sequential basis versus Rs 390 crore in Q4FY25 while the topline increased 4.5% over Rs 5,592 reported by the company in Q4FY25.

ET logo

Live Events


The earnings were announced after market hours and Apollo Hospitals shares ended with minor downtick at Rs 7,253 on the NSE.The company earned its revenues from healthcare services, Retail health & diagnostics, Digital health & pharmacy distribution and also as other income.Healthcare services revenue stood at Rs 2,974 crore in Q1FY26 versus Rs 2,843 crore in Q4FY25 and Rs 2,654 crore in Q1FY25. The retail health & diagnostics revenue stood at Rs 435 crore in Q1FY26 versus Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25 while digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26 versus Rs 2,376 crore in Q4FY25 and Rs 2,082 crore in Q1FY25.Also Read: Vedanta announces second interim dividend of Rs 16 per share; check record date

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of Economic Times)

Read More

Previous Post

Three more giraffe species than previously thought, scientists say

Next Post

Amid ongoing Israeli attacks, ‘the systematic destruction of Gaza City is already underway’: UN rights office

Next Post
Amid ongoing Israeli attacks, ‘the systematic destruction of Gaza City is already underway’: UN rights office

Amid ongoing Israeli attacks, ‘the systematic destruction of Gaza City is already underway’: UN rights office

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin